In Silico Approach towards Designing Virtual Oligopeptides for HRSV
HRSV (human respiratory syncytial virus) is a serious cause of lower respiratory tract illness in infants and young children. Designing inhibitors from the proteins involved in virus replication and infection process provides target for new therapeutic treatments. In the present study, in silico doc...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2014/613293 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849682985053323264 |
|---|---|
| author | Ruchi Jain Shanmughavel Piramanayagam |
| author_facet | Ruchi Jain Shanmughavel Piramanayagam |
| author_sort | Ruchi Jain |
| collection | DOAJ |
| description | HRSV (human respiratory syncytial virus) is a serious cause of lower respiratory tract illness in infants and young children. Designing inhibitors from the proteins involved in virus replication and infection process provides target for new therapeutic treatments. In the present study, in silico docking was performed using motavizumab as a template to design motavizumab derived oligopeptides for developing novel anti-HRSV agents. Additional simulations were conducted to study the conformational propensities of the oligopeptides and confirmed the hypothesis that the designed oligopeptide is highly flexible and capable of assuming stable confirmation. Our study demonstrated the best specific interaction of GEKKLVEAPKS oligopeptide for glycoprotein strain A among various screened oligopeptides. Encouraged by the results, we expect that the proposed scheme will provide rational choices for antibody reengineering which is useful for systematically identifying the possible ways to improve efficacy of existing antibody drugs. |
| format | Article |
| id | doaj-art-d1e81b6d2de248fba71e61ca59c788d3 |
| institution | DOAJ |
| issn | 2356-6140 1537-744X |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-d1e81b6d2de248fba71e61ca59c788d32025-08-20T03:24:02ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/613293613293In Silico Approach towards Designing Virtual Oligopeptides for HRSVRuchi Jain0Shanmughavel Piramanayagam1DBT-Bioinformatics Centre, Computational Biology Lab, Department of Bioinformatics, Bharathiar University, Coimbatore, Tamil Nadu 641 046, IndiaDBT-Bioinformatics Centre, Computational Biology Lab, Department of Bioinformatics, Bharathiar University, Coimbatore, Tamil Nadu 641 046, IndiaHRSV (human respiratory syncytial virus) is a serious cause of lower respiratory tract illness in infants and young children. Designing inhibitors from the proteins involved in virus replication and infection process provides target for new therapeutic treatments. In the present study, in silico docking was performed using motavizumab as a template to design motavizumab derived oligopeptides for developing novel anti-HRSV agents. Additional simulations were conducted to study the conformational propensities of the oligopeptides and confirmed the hypothesis that the designed oligopeptide is highly flexible and capable of assuming stable confirmation. Our study demonstrated the best specific interaction of GEKKLVEAPKS oligopeptide for glycoprotein strain A among various screened oligopeptides. Encouraged by the results, we expect that the proposed scheme will provide rational choices for antibody reengineering which is useful for systematically identifying the possible ways to improve efficacy of existing antibody drugs.http://dx.doi.org/10.1155/2014/613293 |
| spellingShingle | Ruchi Jain Shanmughavel Piramanayagam In Silico Approach towards Designing Virtual Oligopeptides for HRSV The Scientific World Journal |
| title | In Silico Approach towards Designing Virtual Oligopeptides for HRSV |
| title_full | In Silico Approach towards Designing Virtual Oligopeptides for HRSV |
| title_fullStr | In Silico Approach towards Designing Virtual Oligopeptides for HRSV |
| title_full_unstemmed | In Silico Approach towards Designing Virtual Oligopeptides for HRSV |
| title_short | In Silico Approach towards Designing Virtual Oligopeptides for HRSV |
| title_sort | in silico approach towards designing virtual oligopeptides for hrsv |
| url | http://dx.doi.org/10.1155/2014/613293 |
| work_keys_str_mv | AT ruchijain insilicoapproachtowardsdesigningvirtualoligopeptidesforhrsv AT shanmughavelpiramanayagam insilicoapproachtowardsdesigningvirtualoligopeptidesforhrsv |